Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 11/2017

01-11-2017 | Original Article

The impact of breast cancer treatments on sleep quality 1 year after cancer diagnosis

Authors: Filipa Fontes, Susana Pereira, Ana Rute Costa, Marta Gonçalves, Nuno Lunet

Published in: Supportive Care in Cancer | Issue 11/2017

Login to get access

Abstract

Purpose

The increasing number of women living longer with potential side effects of breast cancer treatment highlights the need of a comprehensive assessment of its burden. Therefore, we aimed to quantify the relation between different breast cancer treatments and sleep quality 1 year after diagnosis.

Methods

A cohort of 502 newly diagnosed breast cancer patients was prospectively followed. Sleep quality was evaluated with the Pittsburgh Sleep Quality Index (PSQI), at baseline and at the 1-year follow-up. Odds ratios (OR) were computed to quantify the association between patient characteristics and poor sleep quality (PSQI score >5) at baseline, and relative risks (RR) were computed for the association between treatments and the occurrence of poor sleep quality at 1 year.

Results

A total of 60.2% of the patients had poor sleep quality before breast cancer treatments, especially those with anxiety [OR = 2.86, 95% confidence interval (95%CI) 1.92 to 4.27] or depression (OR = 5.25, 95%CI 2.01 to 13.67). Radiotherapy increased the risk of poor sleep quality at 1 year (RR = 3.71, 95%CI 1.15 to 11.96, for a cumulative dose >50 Gy) and there was a tendency for a higher risk in those submitted to chemotherapy, although not statistically significant.

Conclusions

Our study shows that sleep disturbances are frequent before cancer treatment and confirms their co-occurrence with other medical conditions, such as anxiety and depression. Different breast cancer treatments increase the risk of impaired sleep quality, therefore contributing to the global disability associated with cancer treatments.
Literature
1.
Ferlay J, Soerjomataram I, Ervik M et al (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, France, International Agency for Research on Cancer http://​globocan.​iarc.​fr, Accessed January 1, 2016
2.
Amaro J, Severo M, Vilela S et al (2013) Patterns of breast cancer mortality trends in Europe. Breast 22(3):244–253CrossRef
3.
Allemani C, Weir HK, Carreira H et al (2015) Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010CrossRef
4.
Soerjomataram I, Lortet-Tieulent J, Parkin DM et al (2012) Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380(9856):1840–1850CrossRef
5.
Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH (2002) Sleep and quality of life in breast cancer patients. J Pain Symptom Manag 24(5):471–480CrossRef
6.
Liu L, Fiorentino L, Rissling M et al (2013) Decreased health-related quality of life in women with breast cancer is associated with poor sleep. Behav Sleep Med 11(3):189–206CrossRef
7.
Fiorentino L, Ancoli-Israel S (2006) Insomnia and its treatment in women with breast cancer. Sleep Med Rev 10(6):419–429CrossRef
8.
Denieffe S, Cowman S, Gooney M (2014) Symptoms, clusters and quality of life prior to surgery for breast cancer. J Clin Nurs 23(17–18):2491–2502CrossRef
9.
Savard J, Villa J, Ivers H, Simard S, Morin CM (2009) Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol 27(31):5233–5239CrossRef
10.
Kotronoulas G, Wengstrom Y, Kearney N (2012) A critical review of women’s sleep-wake patterns in the context of neo-/adjuvant chemotherapy for early-stage breast cancer. Breast 21(2):128–141CrossRef
11.
Knobf MT, Sun Y (2005) A longitudinal study of symptoms and self-care activities in women treated with primary radiotherapy for breast cancer. Cancer Nurs 28(3):210–218CrossRef
12.
Costa AR, Fontes F, Pereira S, Goncalves M, Azevedo A, Lunet N (2014) Impact of breast cancer treatments on sleep disturbances—a systematic review. Breast 23(6):697–709CrossRef
13.
Van Onselen C, Paul SM, Lee K et al (2013) Trajectories of sleep disturbance and daytime sleepiness in women before and after surgery for breast cancer. J Pain Symptom Manag 45(2):244–260CrossRef
14.
Pereira S, Fontes F, Sonin T, et al.(2014) Neurological complications of breast cancer: study protocol of a prospective cohort study. BMJ Open;4(10):e006301.CrossRef
15.
Freitas S, Simoes MR, Alves L, Santana I (2011) Montreal cognitive assessment (MoCA): normative study for the Portuguese population. J Clin Exp Neuropsychol 33(9):989–996CrossRef
16.
Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual. Springer, New York
17.
De Vos FY, van Laarhoven HW, Laven JS et al (2012) Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guideline. Crit Rev Oncol Hematol 84(2):252–260CrossRef
18.
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRef
19.
Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M (2007) Validation study of a Portuguese version of the hospital anxiety and depression scale. Psychol Health Med 12(2):225–235 quiz 35-7CrossRef
20.
Snaith RP (2003) The hospital anxiety and depression scale. Health Qual Life Outcomes 1:29CrossRef
21.
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213CrossRef
22.
Marques D, Gomes AA, Meiavia A, Salgueiro A, Carlos Ribeiro J, Dischler J.(2013) Reliability and initial validation of the Pittsburgh sleep quality index, European Portuguese version: a preliminary study in a sample of higher education students. Sleep Med;14(Suppl 1 ):e140.CrossRef
23.
Amaral MO, de Figueiredo Pereira CM, Silva Martins DI, de Serpa CR, Sakellarides CT (2013) Prevalence and risk factors for insomnia among Portuguese adolescents. Eur J Pediatr 172(10):1305–1311CrossRef
24.
Smagula SF, Stone KL, Fabio A, Cauley JA.(2015) Risk factors for sleep disturbances in older adults: evidence from prospective studies. Sleep Med Rev.
25.
Papadimitriou GN, Linkowski P (2005) Sleep disturbance in anxiety disorders. Int Rev Psychiatry 17(4):229–236CrossRef
26.
Desai K, Mao JJ, Su I et al (2013) Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Support Care Cancer 21(1):43–51CrossRef
27.
Colagiuri B, Christensen S, Jensen AB, Price MA, Butow PN, Zachariae R (2011) Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. J Pain Symptom Manag 42(5):710–720CrossRef
28.
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-V). American Psychiatric Association, Washington, DCCrossRef
29.
Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19(3):895–908CrossRef
30.
Berger AM, Wielgus K, Hertzog M, Fischer P, Farr L (2010) Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer 18(1):105–114CrossRef
31.
Ho SY, Rohan KJ, Parent J, Tager FA, McKinley PS (2015) A longitudinal study of depression, fatigue, and sleep disturbances as a symptom cluster in women with breast cancer. J Pain Symptom Manag 49(4):707–715CrossRef
32.
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18(4):743–753CrossRef
33.
Brown LF, Kroenke K (2009) Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 50(5):440–447CrossRef
34.
Bardwell WA, Profant J, Casden DR et al (2008) The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology 17(1):9–18CrossRef
35.
Coles CE, Moody AM, Wilson CB, Burnet NG.(2005) Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Part I—normal tissue complications. Clin Oncol (R Coll Radiol);17(1):16-24.CrossRef
36.
Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW (2011) Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol 29(26):3517–3522CrossRef
37.
Palesh O, Zeitzer JM, Conrad A et al (2008) Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. J Clin Sleep Med 4(5):441–449PubMedPubMedCentral
38.
Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008) Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26(6):971–982CrossRef
39.
Koopman C, Nouriani B, Erickson V et al (2002) Sleep disturbances in women with metastatic breast cancer. Breast J 8(6):362–370CrossRef
40.
Savard J, Simard S, Blanchet J, Ivers H, Morin CM (2001) Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 24(5):583–590CrossRef
41.
Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM (2006) Recommendations for a standard research assessment of insomnia. Sleep 29(9):1155–1173CrossRef
Metadata
Title
The impact of breast cancer treatments on sleep quality 1 year after cancer diagnosis
Authors
Filipa Fontes
Susana Pereira
Ana Rute Costa
Marta Gonçalves
Nuno Lunet
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 11/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3777-6

Other articles of this Issue 11/2017

Supportive Care in Cancer 11/2017 Go to the issue

Original Article

Gender-varying associations between physical activity intensity and mental quality of life in older cancer survivors

Original Article

The impact of personal-, disease- and work-related factors on work ability of women with breast cancer living in the community: a cross-sectional survey study

Original Article

Designing more engaging computer-tailored physical activity behaviour change interventions for breast cancer survivors: lessons from the iMove More for Life study

Original Article

An update in symptom clusters using the Edmonton Symptom Assessment System in a palliative radiotherapy clinic

Original Article

Psychometric testing of the Mandarin version of the 34-item Short-Form Supportive Care Needs Survey in patients with cancer in mainland China

Original Article

Changes in light-, moderate-, and vigorous-intensity physical activity and changes in depressive symptoms in breast cancer survivors: a prospective observational study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits